Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy A Beveridge

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Oncology Practice|September 3, 2011
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databasesJ Russell Hoverman, Thomas H Cartwright, Debra A Patt, et al.
American Health & Drug Benefits|July 4, 2014
Defining Value in Cancer Care: AVBCC 2012 Steering Committee Report, Gene Beed, Gary M Owens, et al.
Leukemia & Lymphoma|August 15, 2003
A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial)Francis J Giles, Carole B Miller, David D Hurd, et al.
Leukemia Research|May 4, 2004
A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapyFrancis J Giles, Roberto Rodriguez, Daniel Weisdorf, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Oncology Practice|September 3, 2011
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databasesJ Russell Hoverman, Thomas H Cartwright, Debra A Patt, et al.
American Health & Drug Benefits|July 4, 2014
Defining Value in Cancer Care: AVBCC 2012 Steering Committee Report, Gene Beed, Gary M Owens, et al.
Leukemia & Lymphoma|August 15, 2003
A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial)Francis J Giles, Carole B Miller, David D Hurd, et al.
Leukemia Research|May 4, 2004
A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapyFrancis J Giles, Roberto Rodriguez, Daniel Weisdorf, et al.
Pageof 2